Treatment with siFga improves the outcome in mouse models of fibrin(ogen)-driven pathologies.

Treatment with siFga improves the outcome in mouse models of fibrin(ogen)-driven pathologies.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal